SEP 30, 2015 6:00 AM PDT

Comparative genome and transcriptome analysis of small cell numbers

Speaker
  • Director, Scientific Applications: NGS & Isothermal Amplifications, QIAGEN
    Biography
      Dr. Christian Korfhage is Director, R&D Scientific Applications, at QIAGEN in Hilden. His responsibilities include the development and evaluation of new amplification and assay technologies and solutions for single cell research. Dr. Korfhage joined QIAGEN in 1997 and has held various positions in Research and Development in the areas of real-time PCR methods, isothermal amplification methods, and single cell technologies. After studying biology, he received his Ph.D. from the Institute of Genetics at the Faculty for Biology (University of Cologne, Germany) in 1993. He also completed postgraduate studies at the Max Planck Institute for Plant Breeding (Cologne) and the Institute of Molecular Neurology (Düsseldorf) in Germany.

    Abstract

    The genome determines changes of the transcription profile upon environmental changes and finally determines how a cell reacts. A comparative genome and transcriptome analysis of the same sample is a tool to explain changes in the transcriptome by features within genome. In order to avoid a mixed transcription profile from multiple cells, it is necessary to analyze a small cell number. For a detailed analysis of the genome and transcriptome, next-generation sequencing (NGS) is a useful method. However, it requires an amount of nucleic acid much higher than that present in a few cells. Therefore, whole genome amplification (WGA) and whole transcriptome amplification (WTA) is prerequisite for NGS. 

    Here, we describe how the genome and the transcriptome can be amplified simultaneously from a few cells in a highly parallel and comparable process. We present application data from cancer and endothelial cells. 


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources